# Understanding the Tardive Dyskinesia Awareness Week Resolution

This is a simple resolution that designates one specific week in May 2021 as "Tardive Dyskinesia Awareness Week." Think of it like how Congress officially recognizes National Cancer Awareness Month or similar observances—it's a formal acknowledgment to draw public attention to a particular health condition.

Tardive dyskinesia is a serious side effect that can develop in people taking certain psychiatric medications, particularly antipsychotics used to treat conditions like schizophrenia and bipolar disorder. The condition causes involuntary, repetitive movements—things like facial grimacing, lip smacking, tongue protrusion, or jerky limb movements that the person can't control. It can be permanent even after someone stops taking the medication, which makes it a significant concern for patients and doctors.

By officially designating this awareness week, Congress is essentially saying this condition deserves more public attention and understanding. The resolution encourages people to learn about tardive dyskinesia, its risks, and how it affects patients. This kind of official recognition can help raise awareness among patients taking these medications, encourage them to discuss the risks with their doctors, and push for more research into prevention and treatment options. It's a symbolic but meaningful step toward making sure people understand the potential side effects of medications they're taking and can make informed decisions with their healthcare providers.

A resolution designating the week of May 2, 2021, through May 8, 2021, as "Tardive Dyskinesia Awareness Week".

Murphy, Christopher

 <p>This resolution designates May 2-May 8, 2021, as Tardive Dyskinesia Awareness Week. Tardive Dyskinesia is a movement disorder characterized by involuntary and uncontrolled movements of muscles in the face, torso, and extremities. It is caused by prolonged use of certain medications, including ones used to treat schizophrenia.</p>